About 2 Trademarks found that are owned by Suzhou Sanegene Bio Co Ltd

Pharmaceutical preparations for the treatment of various diseases, namely, rare ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, oligonucleotide compounds for use in the targeted delivery of Ribonucleic acid interference (RNAi) therapy; Pharmaceutical preparations for use in injection for treatment of rare ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, molecular nanoparticle complexes that act as a platform for the delivery of RNA based drugs to biological cells; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals

Pharmaceutical preparations for the treatment of various diseases, namely, rare ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, oligonucleotide compounds for use in the targeted delivery of Ribonucleic acid interference (RNAi) therapy; Pharmaceutical preparations for use in injection for treatment of rare ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, molecular nanoparticle complexes that act as a platform for the delivery of RNA based drugs to biological cells; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals